Stocks · Health care · Biological Products, (No Diagnostic Substances)

4D Molecular Therapeutics, Inc.

FDMT Clue Score62
United States Fiscal year ends December CIK 0001650648 Results filed 13 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
David Kirn
23 Jan 2024
Chief Executive Officer
Sell
5,696
$18.41
$104.85K
Viking Global Investors LP
4 Jan 2024
10% owner
Sell indirect
540,000
$19.53
$10.55M
David Kirn
22 Feb 2023
Chief Executive Officer
Sell
16,449
$20.22
$332.66K
David Kirn
21 Feb 2023
Chief Executive Officer
Sell
907
$21.49
$19.49K
David Kirn
21 Feb 2023
Chief Executive Officer
Sell
17,090
$20.93
$357.72K
David Kirn
20 Jan 2023
Chief Executive Officer
Sell
8,625
$20.19
$174.13K
David Kirn
19 Jan 2023
Chief Executive Officer
Sell
10,899
$20.03
$218.35K
David Kirn
16 Dec 2022
Chief Executive Officer
Sell
26,349
$23.39
$616.21K
David Kirn
16 Dec 2022
Chief Executive Officer
Sell
27,595
$22.66
$625.37K
David Kirn
15 Dec 2022
Chief Executive Officer
Sell
1,500
$24.13
$36.20K
David Kirn
15 Dec 2022
Chief Executive Officer
Sell
31,433
$23.56
$740.57K
David Schaffer
22 Oct 2021
Director
Sell
1,900
$31.00
$58.89K
David Schaffer
21 Oct 2021
Director
Sell
22,820
$31.56
$720.16K
David Schaffer
20 Oct 2021
Director
Sell
11,565
$31.02
$358.77K
David Schaffer
30 Sep 2021
Director
Sell
4,549
$27.28
$124.08K
David Schaffer
30 Sep 2021
Director
Sell
7,836
$26.69
$209.16K
David Schaffer
29 Sep 2021
Director
Sell
700
$30.06
$21.04K
David Schaffer
29 Sep 2021
Director
Sell
8,365
$29.06
$243.06K
David Schaffer
29 Sep 2021
Director
Sell
7,806
$27.99
$218.51K
David Schaffer
28 Sep 2021
Director
Sell
100
$32.00
$3.20K
David Schaffer
28 Sep 2021
Director
Sell
13,812
$30.52
$421.49K
David Schaffer
27 Sep 2021
Director
Sell
100
$34.19
$3.42K
David Schaffer
27 Sep 2021
Director
Sell
6,157
$33.51
$206.33K
David Schaffer
27 Sep 2021
Director
Sell
13,075
$32.59
$426.08K

What was left out

Form 4 filings counted 142
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 18
Sales straight out of an exercise 54
Sales at will 24
Transactions with no price 0
Shares from compensation/vesting 11,101,263
Sales filed before the plan box existed 22
History held since 17 Dec 2020